Tecfidera Brain Infection Results in FDA Warning Label Update
The FDA is requiring a new label warning detailing the death of a patient due to brain infection for the MS drug Tecfidera.
The FDA is requiring a new label warning detailing the death of a patient due to brain infection for the MS drug Tecfidera.
Following reports that link side effects of Rituxan to fatal brain infections, the FDA is reviewing whether users of the cancer-fighting drug should use the medication for shorter periods of…